Koers Aeolus Pharmaceuticals, Inc. Other OTC
Aandelen
AOLS
US00765G1094
Biotechnologie & Medisch Onderzoek
Omzet 2015 | 3,11 mln. 2,9 mln. | Omzet 2016 | 2,08 mln. 1,94 mln. | Marktkapitalisatie | 28,9 mln. 26,97 mln. |
---|---|---|---|---|---|
Nettowinst (verlies) 2015 | -2 mln. -1,87 mln. | Nettowinst (verlies) 2016 | -3 mln. -2,8 mln. | EV/omzet 2015 | 10,8 x |
Nettoschuld 2015 | 908K 848K | Nettoliquiditeiten 2016 | 3,16 mln. 2,94 mln. | EV/omzet 2016 | 12,4 x |
K/w-verhouding 2015 |
-12
x | K/w-verhouding 2016 |
-4,67
x | Werknemers | - |
Dividendrendement 2015 * |
-
| Dividendrendement 2016 |
-
| Vrij verhandelbaar | 100% |
Managers | Titel | Leeftijd | Van |
---|---|---|---|
John McManus
CEO | Chief Executive Officer | 60 | 01-06-05 |
David Cavalier
CHM | Chairman | 54 | 30-04-04 |
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
David Cavalier
CHM | Chairman | 54 | 30-04-04 |
Jeffrey Scott
BRD | Director/Board Member | 67 | 08-05-13 |
John Clerici
BRD | Director/Board Member | 54 | 08-05-13 |
Vaira. 1 jan. | Kapi. | |
---|---|---|
+0,67% | 42,19 mld. | |
+44,30% | 40,15 mld. | |
-6,20% | 28,31 mld. | |
+6,55% | 24,63 mld. | |
-21,66% | 18,2 mld. | |
+29,96% | 12,01 mld. | |
-1,57% | 11,76 mld. | |
+16,03% | 10,4 mld. | |
-4,80% | 9,94 mld. |